| Add to balance / Manage account | User: | Log out |
| Prospect News home > News index > List of issuers P > Headlines for Proteome Systems Ltd. > News item |
Proteome, FIND partner to develop TB test
By Lisa Kerner
Erie, Pa., Jan. 31 - Proteome Systems said it has signed a formal agreement with the Foundation for Innovative New Diagnostics (FIND) for the development of Proteome's novel tuberculosis (TB) biomarkers for incorporation into a faster, more accurate point-of-care active TB test.
The formal agreement follows a letter of intent signed with FIND, which was previously announced, detailing development milestones and financial and non-financial commitments, according to a company news release.
Proteome's partnership with FIND will provide support to speed the development of the test including clinical material, assistance with clinical trials and fast tracking of registration, officials said.
In return, FIND is granted rights to use resulting reagents for incorporation into an affordable product for the public health sector in developing countries.
"Proteome's innovative biomarker discovery platform has the potential to identify TB proteins in infected individuals and is poised to be an important breakthrough in development of improved TB diagnostics," Giorgio Roscigno, FIND chief executive officer, said in the release.
"Unlike most currently available TB diagnostics, a new test developed employing Proteome's reagents would directly detect proteins expressed by the TB causative microbe Mycobacterium tuberculosis in infected individuals, as well as measuring the severity of an infection," Proteome's head of diagnostics Jenny Harry said. "Such a test would need to be an easily administered POC [point-of-care] system, delivering an accurate result within minutes."
Proteome is a medical technology company based in Sydney, Australia.
FIND is a non-profit Swiss foundation based in Geneva that develops affordable diagnostic products for infectious diseases.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.